Alcon introduces expanded parameters for TOTAL30 for Astigmatism contact lens

News
Article

The lens is now available in a -2.75D cylinder offering, according to a news release.

Blurry vision of city Image credit: AdobeStock/dreamsgraphicdesign

Image credit: AdobeStock/dreamsgraphicdesign

Alcon has announced expanded parameters for TOTAL30 for Astigmatism, which is now available in a -2.75D cylinder offering. The contact lens is the first and only monthly replacement water gradient toric, according to a news release. The new parameters have been available since October 1, 2024.1

“From varying vision correction requirements to replacement schedule preferences, we are innovating to meet the diverse needs of today’s patients,” said Max Wolf, general manager and head of Vision Care and Contact Lenses at Alcon, in the release. “Because astigmatic patients disproportionately suffer from dryness and discomfort,2 the need for outstanding comfort and moisturization in a lens is paramount. With the release of extended parameters for TOTAL30 for Astigmatism in the US, we are delivering an exceptional offering from the TOTAL30 portfolio that fulfils those needs, allowing eye care professionals to reach more patients.

For the TOTAL30 lens family, the PRECISION BALANCE 8|4 lens design provides on-eye stability with a 95% first lens fit success rate. Additionally, the lenses feature Class 1 UV blocking against UVA and UVB rays, with blue-violet light filtration.1

“Patients with expanded parameters deserve innovation just like any other reusable lens wearer,” said Jessilin Quint, OD, MBA, MS, FAAO. “Previously, these patients had very few options and were forced to compromise on comfort, which is why I’m thrilled by this latest innovation from Alcon. Having expanded parameters for TOTAL30 for Astigmatism is a game changer for my patients because of how well the lens performs and how easy it is to order.”

Alcon also has informative materials and signage about TOTAL30 for Astigmatism available in various languages for eye care providers to take advantage of. For access to the materials, eye care providers can reach out to their Alcon representatives, and for more multilingual provider to patient resources, visit Alcon’s website.

References:
  1. Alcon reaffirms its commitment to astigmatic patients offering TOTAL30 for Astigmatism with expanded parameters. News release. Alcon. November 19, 2024. Accessed November 20, 2024.
  2. Young G, Sulley A, Hunt C. Prevalence of astigmatism in relation to soft contact lens fitting. Eye Contact Lens. 2011;37:20-25.
Recent Videos
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
Nate Lighthizer, OD, FAAO, overviews a handful of YAG laser procedures in his AAOpt presentation.
Susan Gromacki, OD, MS, FAAO, FSLS, details a panel that provided a complete course on keratoconus.
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
© 2024 MJH Life Sciences

All rights reserved.